Biophytis S.A. (BPTSY)
USD 3.05
(0.0%)
USD 3.05
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -17.02 Million EUR | 27.51% |
| 2022 | -25.92 Million EUR | 26.89% |
| 2021 | -35.46 Million EUR | -13.79% |
| 2020 | -31.17 Million EUR | -46.68% |
| 2019 | -21.25 Million USD | -32.63% |
| 2018 | -16.02 Million USD | -17.07% |
| 2017 | -13.68 Million USD | -63.49% |
| 2016 | -8.37 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -3135.86 USD | 37.25% |
| 2024 Q2 | -3113.02 USD | 0.0% |
| 2023 Q4 | -5112.61 USD | -4.43% |
| 2023 FY | -17.02 Million EUR | 29.69% |
| 2023 Q1 | -4210.87 USD | 33.45% |
| 2023 Q3 | -4895.87 USD | -15.57% |
| 2023 Q2 | -4236.14 USD | -0.6% |
| 2022 FY | -24.21 Million EUR | 22.29% |
| 2022 Q2 | -6494.50 USD | 0.0% |
| 2022 Q4 | -6327.23 USD | 0.0% |
| 2021 Q2 | -7854.01 USD | 0.0% |
| 2021 Q4 | -10.19 Thousand USD | 0.0% |
| 2021 FY | -31.16 Million EUR | -22.13% |
| 2020 FY | -25.51 Million EUR | -28.17% |
| 2020 Q4 | -7218.42 USD | 0.0% |
| 2020 Q2 | -7696.93 USD | 0.0% |
| 2019 Q4 | -4906.34 USD | 0.0% |
| 2019 FY | -19.9 Million USD | -20.65% |
| 2018 FY | -16.5 Million USD | -28.23% |
| 2017 FY | -12.86 Million USD | -46.26% |
| 2016 FY | -8.79 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 77.287% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -158.907% |
| SQZ Biotechnologies Company | -79.46 Million USD | 78.574% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 132.137% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 126.14% |
| Mesoblast Limited | -87.95 Million USD | 80.643% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -835.223% |
| Genus plc | 7.9 Million USD | 315.519% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -56.32% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -358.893% |
| Marizyme, Inc. | -65.34 Million USD | 73.945% |
| ContraFect Corporation | -65.15 Million USD | 73.868% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -92.515% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -248.461% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -885.612% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -488.647% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -111.249% |
| MultiCell Technologies, Inc. | -380.07 USD | -4479601.108% |
| Accustem Sciences Inc. | -3.74 Million USD | -354.461% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 67.063% |
| EV Biologics, Inc. | -1.26 Million USD | -1243.662% |
| Q BioMed Inc. | -2.05 Million USD | -729.689% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -356.094% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -2592.254% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -615.117% |
| Biomind Labs Inc. | -1.21 Million USD | -1302.103% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -10.54 Million USD | -61.414% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -115.435% |
| Skye Bioscience, Inc. | -37.64 Million USD | 54.772% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -684.676% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -113588.568% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -143.826% |
| IMV Inc. | -36.48 Million USD | 53.335% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | -7.274% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -192.681% |
| GB Sciences, Inc. | -1.36 Million USD | -1150.37% |
| Alpha Cognition Inc. | -13.77 Million USD | -23.623% |
| HST Global, Inc. | -146.21 Thousand USD | -11544.894% |
| CSL Limited | 2.64 Billion USD | 100.644% |
| Halberd Corporation | -79.67 Thousand USD | -21269.045% |
| Enzolytics Inc. | -2.17 Million USD | -682.146% |
| Resverlogix Corp. | -3.61 Million USD | -371.634% |
| Affymax, Inc. | -14.42 Million USD | -18.039% |
| SYBLEU INC | -180.3 Thousand USD | -9342.941% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -436.855% |
| argenx SE | -295.05 Million USD | 94.23% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 72.801% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 17473.469% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -328.543% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -462.632% |
| AVAX Technologies, Inc. | -6.41 Million USD | -165.465% |
| Zenith Capital Corp. | -10.59 Million USD | -60.683% |
| Genscript Biotech Corporation | -95.47 Million USD | 82.167% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -73155.314% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -310.667% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -28069.802% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 71.493% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -448.913% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.05 Million USD | -1512.224% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -773.465% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -345.824% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -749.128% |
| BioStem Technologies, Inc. | -8.48 Million USD | -100.708% |
| ONE Bio Corp. | 8.67 Million USD | 296.229% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -3757.543% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -1174.944% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -870.269% |
| Agentix Corp. | -1.37 Million USD | -1138.965% |
| LadRx Corporation | 400.44 Thousand USD | 4351.791% |
| Cell Source, Inc. | -5.32 Million USD | -219.965% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -3997.921% |
| Regen BioPharma, Inc. | 1.02 Million USD | 1763.495% |
| Regen BioPharma, Inc. | 1.02 Million USD | 1763.495% |
| NovAccess Global Inc. | -4.76 Million USD | -257.0% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 345.877% |
| Itoco Inc. | -1.86 Million USD | -810.971% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -283.25% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -920.132% |
| Kadimastem Ltd | -3.3 Million USD | -414.785% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -6127.46% |
| CytoDyn Inc. | -49.84 Million USD | 65.839% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -21442.9% |
| Mobile Lads Corp. | -2.26 Million USD | -652.267% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -7363.387% |
| Qrons Inc. | -789.34 Thousand USD | -2056.973% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -1708.335% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.08 Million USD | -715.546% |
| Rebus Holdings, Inc. | -1.02 Million USD | -1569.216% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -955.721% |
| International Stem Cell Corporation | -131 Thousand USD | -12896.947% |
| Bioxytran, Inc. | -4.28 Million USD | -297.804% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -31271.61% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -572.899% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 64.582% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -705.393% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -2080.341% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -437.437% |
| Neutra Corp. | -233.46 Thousand USD | -7192.742% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 16.091% |
| PureTech Health plc | -65.69 Million USD | 74.084% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 19.94% |
| IXICO plc | -1.17 Million USD | -1345.331% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -71.512% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 70.197% |
| CSL Limited | 2.64 Billion USD | 100.644% |
| Cellectis S.A. | -103.17 Million USD | 83.498% |